Clinical trial
Perioperative Percutaneous Electrical Nerve Stimulation Via a Wearable Equipment on Postoperative Nausea and Vomiting(PONV) in Patients Undergoing Laparoscopy Abdominal Surgery: a Prospective Randomized Controlled Trial
Name
I-23PJ1712
Description
This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting.
Trial arms
Trial start
2024-01-12
Estimated PCD
2024-12-30
Trial end
2024-12-30
Status
Recruiting
Phase
Early phase I
Treatment
electrical stimualtion via EmeTerm bracelet
We planned to exert electrical stimulation via the bracelet.
Arms:
stimulation group
antimetic drugs( dexamethasone,ondansetron)
Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.
Arms:
control group, stimulation group
Size
302
Primary endpoint
Incidence of postoperative nausea and vomiting(PONV)
24 hours after surgery
Eligibility criteria
Inclusion Criteria:
1. Patients aged 18-65 years;
2. Patients undergoing elective laparoscopic surgery;
3. American Society of Anaesthesiologists(ASA) Grade 1 to 3;
4. Anesthesia: General Anesthesia, Tracheal Intubation;
5. BMI: ≥18, \<28;
6. Gender: female
7. Patients or their family members are able to comprehend the study protocol and are willing to participate in this research by providing written informed consent.
Exclusion Criteria:
1. There are incisions or scars in the wearing position of the device;
2. There is a local infection in the wearing position of the device;
3. upper extremity nerve injury;
4. history of spinal cord surgery;
5. Participated in other clinical trials within 4 weeks;
6. suffering from severe central nervous system disease or mental disorder;
7. Patients need to return to the ICU after surgery.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 302, 'type': 'ESTIMATED'}}
Updated at
2024-05-09
1 organization
1 product
1 indication
Organization
Peking Union Medical College HospitalProduct
Dexamethasone + OndansetronIndication
Postoperative Nausea and Vomiting